The Diagnosis and Applied Therapeutics is our main mission. At a time when the monopolization of Aesthetics is leading to the decline of Clinical Dermatology, we are focusing primarily on Bedside Dermatology to meet the needs of the patient. Our request is that no diagnosis which could lead to guaranteeing effective subsequent treatment is missed. In addition, advances in Pharmacology have today armed the therapeutic quiver of the Dermatologist, allowing him to effectively control a multitude of previously refractory to treatment diseases, such as acne, atopic dermatitis, seborrheic dermatitis, rosacea, eczema/atopic dermatitis, psoriasis, urticaria in its various forms (chronic idiopathic/spontaneous, cholinergic, etc.), vitiligo, lichen
planus, lichen sclerosus, alopecia areata, hidradenitis suppurrativa, etc.
Our goal is to open a new “range” of care to all people suffering from chronic skin diseases. Therapeutic innovations, eclipsed by the domination of aesthetic medicine at the level of private dermatology practices, are either not widely known or are considered to be the exclusive domain of large hospital care units. And yet, over the past five years, there has been an unprecedented cosmogony in the treatment of psoriasis, vitiligo, alopecia areata and other inflammatory skin diseases, which has radically changed the lives of many patients in Western Europe, America, Japan, South Korea, Israel and elsewhere. A private dermatology practice in Athens aiming to be at the forefront in providing medical services must embrace these therapeutic innovations.
The specialization and continuing training of the doctor in France, as well as the parallel maintenance of his clinical activity in Paris (medical practice in the 7th arrondissement of Paris, 29 avenue de Suffren), as well as his academic activities (mainly the study of scabies and autoimmune diseases), guarantee constantly updated knowledge in Applied Therapeutics.
The role of the dermatologist as a clinician worthy of the name, in addition to diagnosis and treatment, includes the ability to educate the patient and his environment about the disease, its causes and pathogenesis, as well as prevention. As an ''educator'', the doctor listens to the patient, analyzes the psychological burden that the illness exerts on them, dispels the patient's preconceived ideas without criticizing.
On the path where Dermatology crosses Rheumatology and Internal Medicine, the importance of the clinical dimension of our Specialty is revealed.
The dermatologist can recognize clinical signs appearing on the skin and indicating an underlying immunological, haematological or oncological disease, as sometimes happens in cases of systemic lupus erythematosus, various forms of arthritis, various lymphomas, inflammatory gut diseases and other systemic diseases.
Findings that can easily be classified simply as “pimples” are sometimes linked to rashes indicative of major systemic diseases. The dermatologist must be “vigilant”.
Infectious skin diseases are caused by microorganisms such as bacteria, fungi, parasites or viruses and are potentially contagious. The most common conditions in this category are given as examples:
* We have extensive experience in the diagnosis and treatment of the human scabies which is the subject of the doctor's doctoral thesis. He has contributed to the proposal and implementation of French protocols to deal with the influx of scabies in diverse care units for the elderly in the Attica basin, so that they become models in terms of elimination of the endemic infectious load in their premises.
